INSULINOTROPIC AND GLUCAGONOTROPIC EFFECTS OF BETA-LACTOGLOBULIN

The present invention pertains to a) beta-lactoglobulin or b) a nutritional composition comprising beta-lactoglobulin for use in preventing and/or treating a metabolic disorder and/or muscle atrophy. It also pertains to a method of preventing and/or treating a metabolic disorder and/or muscle atroph...

Full description

Saved in:
Bibliographic Details
Main Authors MØLLER, NIELS, CHRISTENSEN, BRITT, JÆGER, TANJA CHRISTINE, MOSE, MAIKE, FREDERIKSEN, PERNILLE DORTHEA, LAURIDSEN, KASPER BØGELUND, MIKKELSEN, ULLA RAMER, NIELSEN, SØREN BANG, SMEDEGAARD, STINE BECH, HULMAN, ADAM, RITTIG, NIKOLAJ FIBIGER, MARKHOLM, MIE
Format Patent
LanguageEnglish
Polish
Published 20.05.2024
Subjects
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

Abstract The present invention pertains to a) beta-lactoglobulin or b) a nutritional composition comprising beta-lactoglobulin for use in preventing and/or treating a metabolic disorder and/or muscle atrophy. It also pertains to a method of preventing and/or treating a metabolic disorder and/or muscle atrophy in a subject. It furthermore pertains to use of a) beta-lactoglobulin or b) a nutritional composition comprising beta-lactoglobulin for increasing the level of insulin and/or glucagon in the blood of a subject and the present invention also pertains to a non-therapeutic use or method of a) beta-lactoglobulin or b) a nutritional composition comprising BLG. It also pertains to beta-lactoglobulin (BLG) for use in preventing and/or treating diabetes or prediabetes in a subject. It furthermore pertains to a nutritional composition for use in preventing and/or treating diabetes or prediabetes in a subject.
AbstractList The present invention pertains to a) beta-lactoglobulin or b) a nutritional composition comprising beta-lactoglobulin for use in preventing and/or treating a metabolic disorder and/or muscle atrophy. It also pertains to a method of preventing and/or treating a metabolic disorder and/or muscle atrophy in a subject. It furthermore pertains to use of a) beta-lactoglobulin or b) a nutritional composition comprising beta-lactoglobulin for increasing the level of insulin and/or glucagon in the blood of a subject and the present invention also pertains to a non-therapeutic use or method of a) beta-lactoglobulin or b) a nutritional composition comprising BLG. It also pertains to beta-lactoglobulin (BLG) for use in preventing and/or treating diabetes or prediabetes in a subject. It furthermore pertains to a nutritional composition for use in preventing and/or treating diabetes or prediabetes in a subject.
Author LAURIDSEN, KASPER BØGELUND
FREDERIKSEN, PERNILLE DORTHEA
CHRISTENSEN, BRITT
NIELSEN, SØREN BANG
JÆGER, TANJA CHRISTINE
MØLLER, NIELS
SMEDEGAARD, STINE BECH
MOSE, MAIKE
HULMAN, ADAM
RITTIG, NIKOLAJ FIBIGER
MIKKELSEN, ULLA RAMER
MARKHOLM, MIE
Author_xml – fullname: MØLLER, NIELS
– fullname: CHRISTENSEN, BRITT
– fullname: JÆGER, TANJA CHRISTINE
– fullname: MOSE, MAIKE
– fullname: FREDERIKSEN, PERNILLE DORTHEA
– fullname: LAURIDSEN, KASPER BØGELUND
– fullname: MIKKELSEN, ULLA RAMER
– fullname: NIELSEN, SØREN BANG
– fullname: SMEDEGAARD, STINE BECH
– fullname: HULMAN, ADAM
– fullname: RITTIG, NIKOLAJ FIBIGER
– fullname: MARKHOLM, MIE
BookMark eNrjYmDJy89L5WRw8PQLDvXx9PMPCfIP8HRWcPRzUXD3CXV2dPeHi7m6ubk6hwQr-LspOLmGOOr6ODqH-Lv7-DuBNPIwsKYl5hSn8kJpbgZFN9cQZw_d1IL8-NTigsTk1LzUkvgAHxMDM0NjS8uQEGNjYtQAAPg_LUE
ContentType Patent
DBID EVB
DatabaseName esp@cenet
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
DocumentTitleAlternate DZIAŁANIE INSULINOTROPOWE I GLUKAGONOTROPOWE BETA-LAKTOGLOBULINY
ExternalDocumentID PL4061399TT3
GroupedDBID EVB
ID FETCH-epo_espacenet_PL4061399TT33
IEDL.DBID EVB
IngestDate Fri Jul 19 12:45:30 EDT 2024
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language English
Polish
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_PL4061399TT33
Notes Application Number: PL20200808127T
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20240520&DB=EPODOC&CC=PL&NR=4061399T3
ParticipantIDs epo_espacenet_PL4061399TT3
PublicationCentury 2000
PublicationDate 20240520
PublicationDateYYYYMMDD 2024-05-20
PublicationDate_xml – month: 05
  year: 2024
  text: 20240520
  day: 20
PublicationDecade 2020
PublicationYear 2024
RelatedCompanies Arla Foods amba
RelatedCompanies_xml – name: Arla Foods amba
Score 3.5385792
Snippet The present invention pertains to a) beta-lactoglobulin or b) a nutritional composition comprising beta-lactoglobulin for use in preventing and/or treating a...
SourceID epo
SourceType Open Access Repository
SubjectTerms HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Title INSULINOTROPIC AND GLUCAGONOTROPIC EFFECTS OF BETA-LACTOGLOBULIN
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20240520&DB=EPODOC&locale=&CC=PL&NR=4061399T3
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3dS8MwED_mFPVNpzLnBxWkb8UuWTv7UHRN223SNWVmsrfRpC0MZBuu4r9vUrbpi76FCzkugcvvPnIXgHv8aGWpmUsnx8Zdo8NT2-CZcAwsbI5wWrTNTGV0R7E9mHRepta0BvNtLUzVJ_Srao4oNUpIfS-r-3r1E8Tyq7eV6wc-l6TlU8hcX994xxKeLGTqvucGCfUp0Qlxk0iPx26FW47D8B7sSyu6q5QhePNUUcrqN6KEJ3CQSGaL8hRqq_cGHJHtx2sNOBxt8t1yuFG99Rk8Szd7Eg1jysY0GRKtF_taP5qoiNmOJo3OgLBXjYaaF7CeEfUIo_2IemrhOdyFASMDQ4oy2217lkRboRnGF1BfLBd5EzSOkBDYERkqnI7oFhyjQrSLLM_aVoFTcQmtv_m0_pu8gmN1hCo3jsxrqJcfn_mNhNyS31aH9Q2Ta4G3
link.rule.ids 230,309,783,888,25576,76876
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3dS8MwED_mFOebTkXnVwXpW7FL1s4-FF3TdptmbZmZ7K00aQsD2Yar-O-blm36om_hQo5L4Jf7yl0A7vCDkSZ6Jp0cE3e1Dk9MjafC0rAwOcJJ3tbTMqM7CszBpPM8NaY1mG1qYao-oV9Vc0SJKCHxXlT39fIniOVWbytX93wmSYtHn9muuvaOpXoykK66ju1FoRsSlRA7omowtiu9ZVkM78CutLC7JRi8N6csSln-1ij-IexFktm8OILa8r0JDbL5eK0J-6N1vlsO19BbHcOTdLMndBiEbBxGQ6L0Alfp00kZMdvSpNHpEfaqhL7ieKyn0R5hYZ-GTrnwBG59j5GBJkWJt9uOI7oRmmF8CvX5Yp6dgcIREgJbIkW51RHdnGOUi3aeZmnbyHEizqH1N5_Wf5M30BiwEY2lSC8XcFAeZ5knR_ol1IuPz-xKqt-CX1cH9w3UiISq
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=INSULINOTROPIC+AND+GLUCAGONOTROPIC+EFFECTS+OF+BETA-LACTOGLOBULIN&rft.inventor=M%C3%98LLER%2C+NIELS&rft.inventor=CHRISTENSEN%2C+BRITT&rft.inventor=J%C3%86GER%2C+TANJA+CHRISTINE&rft.inventor=MOSE%2C+MAIKE&rft.inventor=FREDERIKSEN%2C+PERNILLE+DORTHEA&rft.inventor=LAURIDSEN%2C+KASPER+B%C3%98GELUND&rft.inventor=MIKKELSEN%2C+ULLA+RAMER&rft.inventor=NIELSEN%2C+S%C3%98REN+BANG&rft.inventor=SMEDEGAARD%2C+STINE+BECH&rft.inventor=HULMAN%2C+ADAM&rft.inventor=RITTIG%2C+NIKOLAJ+FIBIGER&rft.inventor=MARKHOLM%2C+MIE&rft.date=2024-05-20&rft.externalDBID=T3&rft.externalDocID=PL4061399TT3